Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease

World Journal of Gastroenterology

Volumn 13, Issue 30, 2007, Pages 4100-4102

  Pai, Vikas ^a   Pai, Nitin ^a  

^a Pai Clinic   (India)

Author keywords

Dexrabeprazole R(+) rabeprazole; Efficacy; Gastroesophageal reflux disease; Safety

Indexed keywords

DEXRABEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SHORT SURVEY; VISUAL ANALOG SCALE;

EID: 34548251842     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i30.4100     Document Type: Short Survey

References (5)

1. Bodhankar SL, Jain BB, Ahire BP, Daude RB, Shitole PP. The effect of rabeprazole and its isomers on histamine and aspirin induced ulcers in rats. Indian J Pharmacol 2006; 38: 357-358
2. Miura M, Kagaya H, Tada H, Uno T, Yasui-Furukori N, Tateishi T, Suzuki T. Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. Br J Clin Pharmacol 2006; 61: 315-320
3. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 1987; 40: 1129-1133
4. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo, M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
5. Pai V, Pai N. Recent Developments: Chiral switch in PPI therapy: S (-) Pantoprazole. Br Med J-South Asia Edition 2006; 22: 112